Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Función Cognitiva y Regulación Afectiva en Meditadores (CALM)

5 de noviembre de 2026 actualizado por: Balachundhar Subramaniam

This is a prospective cohort study with 52 meditators and 52 controls. These groups will be contacted at a singular timepoint, during which they will take surveys and cognitive tests, which will be used to assess cognitive and emotional outcomes. The meditator group will be recruited from a pool of healthy individuals who have learned meditation practices such as those taught by the Isha Foundation (e.g., Shambhavi Mahamudra Kriya, Shoonya, Samyama breath-watching, etc.) Meditation-naïve individuals will be recruited into the control group.

Descripción general del estudio

Descripción detallada

This is a prospective cohort study with 52 meditators and 52 controls. These groups will be contacted at a singular timepoint, during which they will take surveys and cognitive tests, which will be used to assess cognitive and emotional outcomes. The meditator group will be recruited from a pool of healthy individuals who have learned meditation practices such as those taught by the Isha Foundation (e.g., Shambhavi Mahamudra Kriya, Shoonya, Samyama breath-watching, etc.) Meditation-naïve individuals will be recruited into the control group. Despite allocation to 2 separate cohorts, both groups will be subjected to identical questionnaires and tasks at the singular timepoint. Further, none of the above practices are being taught by the study team. Rather, the investigators are only looking to study the effects of the aforementioned practices on participants through validated survey questionnaires and cognitive tasks.

Study Procedure: Following e-consent and enrollment into the study, participants are asked to complete electronic surveys and cognitive tasks. These will either be completed virtually on the participants' own device or on a BIDMC-approved device brought to the participant by the study team. (Further details on the remote administration of surveys and cognitive tasks explained below)

Questionnaire: The following questionnaires are incorporated into the study and will be administered to the study participants at a single timepoint.

Demographic, medical history, past meditation experience, and habits: Collects demographic details (age, ethnicity, gender, education/employment, marital status, number of children, country of residence), meditation exposure and duration of practice, past cognitive training, alcohol use, and smoking.

Cognitive Emotional Regulation Questionnaire (CERQ): This survey aims to collect information on a person's thoughts after having experienced a negative event.

Positive And Negative Affect Schedule (PANAS): Comprises two mood scales measuring positive affect and negative affect. Participants respond to a 20-item test using a 5-point scale that ranges from very slightly or not at all (1) to extremely (5). Scores can range from 10-50 for both the Positive and Negative affect with lower scores representing lower levels of affect and higher scores representing higher levels of affect.

Four-Item Patient Health Questionnaires (PHQ-4) for Anxiety & Depression: Assesses anxiety and depression. Scores range from 0-12 with subscales for anxiety (items 1-2) and depression (items 3-4); scores greater than 3 on each subscale are considered positive.

Perceived Stress Scale (PSS): 10-question validated instrument that assesses stress. Participants are asked to rate on a scale of 0 (never) to 4 (very often) how often they agree with various statements. Items from each of the 10 questions are then summed to create a total perceived stress score. Please see the survey details in the attached "Study Questionnaire" attachment.

Cognitive Tasks: Participants will be asked to complete a set of cognitive tasks to assess executive function, attention, memory, and affect regulation. The tasks would require participants to respond in a specific manner to certain stimuli based on the instructions appearing on the screen. The tasks may also contain images with positive or negative emotional content. Some examples of the tasks that may be used in this study are provided below.

Multi-Source Interference Task (MSIT): Participants are presented with a sequence of three numbers in each trial and are asked to identify and press the key corresponding to the number that is not repeated. In "congruent" trials, the target number appears in the spot corresponding to its value and is flanked by zeros (e.g., "0 2 0"). In "incongruent" trials, the target number is in a spot that does not correspond to its value and is flanked by a non-zero digit (e.g., "3 3 2"). Images with positive, negative, or neutral emotional content are presented simultaneously with the number sequences to test emotional regulation.

N-back Task: Participants are presented with a sequence of letters. Participants are given two keys they can respond with. They are asked to press one key if the current letter is the same as the letter that was presented n letters back, and press the other key if the current letter does not match the letter that was presented n letters back.

These cognitive tasks will be either administered remotely through a secure online cognitive task hosting platform such as Pavlovia (pavlovia.org). Participants will be provided the link to the task on the online platform, and will only be asked to enter their de-identified study ID (e.g., CALM01, CALM02). This link will be unique to the study and will be generated and sent to participants once they enroll in the study.

Tipo de estudio

De observación

Inscripción (Estimado)

104

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Ubicaciones de estudio

    • Massachusetts
      • Boston, Massachusetts, Estados Unidos, 02215
        • Reclutamiento
        • BIDMC

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra no probabilística

Población de estudio

Subjects will not be recruited based on race, ethnicity, or gender. However, it is not clear whether the final study sample will contain a representative spread of the racial and gender makeup. There is no reason to exclude pregnant women from this protocol.

Descripción

Inclusion Criteria:

  • Participants must be able to read and understand English.
  • Meditators: Participants must regularly practice meditation (4 or more times per week).
  • Controls: Participants must not regularly practice meditation (4 or more times per week)

Exclusion Criteria:

  • Below the age of 18.
  • Participants not living in the US.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Modelos observacionales: COHORT
  • Perspectivas temporales: CROSS_SECTIONAL

Cohortes e Intervenciones

Grupo / Cohorte
Meditators

Participants who regularly practice meditation (4 or more times per week)

Controls

Participants who do not regularly practice meditation (4 or more times per week)

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Multi-Source Interference Task (MSIT)
Periodo de tiempo: within one week of consent

Participants are presented with a sequence of three numbers in each trial and are asked to identify and press the key corresponding to the number that is not repeated. In "congruent" trials, the target number appears in the spot corresponding to its value and is flanked by zeros (e.g., "0 2 0"). In "incongruent" trials, the target number is in a spot that does not correspond to its value and is flanked by a non-zero digit (e.g., "3 3 2"). Images with positive, negative, or neutral emotional content are presented simultaneously with the number sequences to test emotional regulation.

within one week of consent
N-back Task
Periodo de tiempo: within one week of consent

Participants are presented with a sequence of letters. Participants are given two keys they can respond with. They are asked to press one key if the current letter is the same as the letter that was presented n letters back, and press the other key if the current letter does not match the letter that was presented n letters back.

within one week of consent

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Cognitive Emotional Regulation Questionnaire (CERQ)
Periodo de tiempo: within one week of consent

This survey aims to collect information on a person's thoughts after having experienced a negative event. Comprised of 36-items, with scores from 1 (never) to 5 (always), total subscale scores range from 4 to 20. Higher subscale scores indicate increased frequency of use for the specified regulation strategy.

within one week of consent
Positive And Negative Affect Schedule (PANAS)
Periodo de tiempo: within one week of consent

Comprises two mood scales measuring positive affect and negative affect. Participants respond to a 20-item test using a 5-point scale that ranges from very slightly or not at all (1) to extremely (5). Total sScores can range from 10-50 for both the Positive and Negative affect with lower scores representing lower levels of affect and higher scores representing higher levels of affect.

within one week of consent
Four-Item Patient Health Questionnaires (PHQ-4) for Anxiety & Depression
Periodo de tiempo: within one week of consent

Total scores range from 0-12 with subscales for anxiety (items 1-2) and depression (items 3-4); scores greater than 3 on each subscale are considered positive. Higher scores indicate increased anxiety/depression symptoms.

within one week of consent
Perceived Stress Scale (PSS)
Periodo de tiempo: within one week of consent

10-question validated instrument that assesses stress. Participants are asked to rate on a scale of 0 (never) to 4 (very often) how often they agree with various statements. Items from each of the 10 questions are then summed to create a total perceived stress score, with a minimum score of 0 and maximum score of 40. Higher scores indicate a higher level or perceived stress.

within one week of consent

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

9 de febrero de 2024

Finalización primaria (Estimado)

31 de diciembre de 2027

Finalización del estudio (Estimado)

31 de diciembre de 2027

Fechas de registro del estudio

Enviado por primera vez

13 de enero de 2026

Primero enviado que cumplió con los criterios de control de calidad

16 de abril de 2026

Publicado por primera vez (Actual)

23 de abril de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

10 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

5 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Palabras clave

Otros números de identificación del estudio

  • 2023P000588

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir